MoonLake Immunotherapeutics (MLTX) Q1 2023 Earnings

31MayExpected
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.54
-0.36
-0.18
0

Details

Expected EPS
-0.3267
Actual EPS
0
Surprise EPS
0.33
Surprise Percent
+100%

Description

MoonLake Immunotherapeutics (MLTX) will report earnings of for Q1 2023 on May 31, 2023.

0 Comments

Share your thoughts